| TEMPLATE ID | Kidney biopsy use case 1 |
|---|---|
| Concept | Kidney biopsy use case 1 |
| Description | Not Specified |
| Purpose | Not Specified |
| References | |
| Other Details (Language Independent) |
|
| Language used | nb |
| Citeable Identifier | 1078.60.670 |
| Root archetype id | openEHR-EHR-COMPOSITION.report.v1 |
| Rapport | Rapport: Dokument som brukes for å kommunisere informasjon til andre, ofte som svar på en forespørsel. |
| Other Context | |
| Rapport ID | Rapport ID: Rapportidentifikator. |
| Status | Status: Status for hele rapporten. NB: Dette er ikke status for enkeltkomponentene i rapporten. |
| Laboratoriesvar | Laboratoriesvar: Funn og tolkning av laboratorieanalyse utført på prøvemateriale fra pasient. Denne arketypen kan brukes for å registrere en enkeltverdi av en analyse, men vil ofte bli spesialisert eller lagt inn i en templat for å representere flere verdier eller pakker av analyser. Denne arketypen fungerer også som forelder for spesialiserte laboratoresvar-arketyper, for eksempel mikrobiologi eller patologi. |
| Data | Data: *@ internal @(en) |
| Uspesifisert hendelse | Uspesifisert hendelse: Standard, uspesifisert tidspunkt eller tidsintervall som kan defineres mer eksplisitt i en templat eller i en applikasjon. |
| Data | Data: *@ internal @(en) |
| Kidney biopsy | Kidney biopsy: Identifikasjon av den utførte analysen, av og til inkludert prøvetype og pasientens tilstand Et prøveresultat kan gjelde for en enkelt analyse eller en gruppe av analyser, inkludert analysepakker. Koding med en terminologi, eventuelt med en prekoordinert term inkludert prøvetype er å foretrekke, hvis mulig. Kan bli kodet med LOINC eller SNOMED CT eller nasjonale laboratoriekodeverk. Eksempler kan være "Glukose", "Urea og elektrolytter", "Dyrkning", "Kortisol (morgen)" eller "Leverbiopsi". |
| Specimen | Specimen: To record details of a laboratory specimen. |
| Datetime collected | Datetime collected: The date and time that collection has been ordered to take place or has taken place. |
| Specimen collector identifier | Specimen collector identifier: Identifier of the person or agency responsible for collecting the specimen. Optional[{fhir_mapping=Specimen.collection.collector}] |
| Number of containers | Number of containers: The total number of containers holding this specimen. >=0 |
| Specimen quality | Specimen quality: Problems with the received specimen. |
| Comment | Comment: An additional text comment on the quality of the received specimen. |
| Processing | Processing: Workflow of specimen processing/handling. |
| Datetime received | Datetime received: The date and time that the sample was received at the laboratory. Optional[{fhir_mapping=Specimen.receivedTime}] |
| Laboratory specimen identifier | Laboratory specimen identifier: Unique identifier of the specimen, normally assigned by the laboratory. Sometimes called the Accession Identifier. Optional[{fhir_mapping=Specimen.accessionIdentifier}] Annotations
|
| Analysestatus | Analysestatus: Overordnet status på analyseresultatet.
|
| Dato/tid svarrapport | Dato/tid svarrapport: Dato og/eller tidspunkt hele svaret var utstedt for svarrapporten. |
| Tilgjengelig klinisk informasjon | Tilgjengelig klinisk informasjon: Beskrivelse av klinisk informasjon som er tilgjengelig på tolkningstidspunktet, noe som kan inkludere en lenke til den originale kliniske informasjonen som ble gitt i rekvisisjonen. I HL7 FHIR lagres denne informasjonen innen lenket requestDetail.clinical. |
| Container 1 | Container 1: Findings and interpretation of histopathology (anatomic pathology) tests performed on tissues and body fluids. |
| Macroscopic findings | Macroscopic findings: A group of findings within the histopathology examination. The Runtime name constraint allows identification of the type of histopathology examination performed. |
| Histopathology finding | Histopathology finding: Details of an individual histopathology finding, often related to a specific anatomical location or specimen. |
| Tissue available | Tissue available: True if the tissue is available for examination. |
| Specimen | Specimen: To record details of a laboratory specimen. |
| Fysiske egenskaper til et objekt | Fysiske egenskaper til et objekt: For registrering av de fysiske egenskaper til et objekt som en kroppsdel eller en lesjon. |
| Navn på det fysiske objektet | Navn på det fysiske objektet: Den aktuelle gjenstanden. Kan være en kroppsdel, enhet eller prøve.
|
| Dimensjon | Dimensjon: Dimensjonene til objektet. |
| Lengde | Lengde: Lengden til objektet. |
| Bilde | Bilde: Bilde av objektet. |
| Fysiske egenskaper til et objekt #1 | Fysiske egenskaper til et objekt #1: For registrering av de fysiske egenskaper til et objekt som en kroppsdel eller en lesjon. |
| Navn på det fysiske objektet | Navn på det fysiske objektet: Den aktuelle gjenstanden. Kan være en kroppsdel, enhet eller prøve.
|
| Dimensjon | Dimensjon: Dimensjonene til objektet. |
| Lengde | Lengde: Lengden til objektet. |
| Bilde | Bilde: Bilde av objektet. |
| Specimen container | Specimen container: Details of a specimen container. This is often integral to workflow and reporting of pathology specimens, particularly anatomical and histological pathology specimens. |
| Container additive | Container additive: Any special fixative or transport medium requirements. |
| Description | Description: A narrative description of the histopathology finding. |
| Description | Description: A narrative description of the group of histopathology findings. |
| Microscopic findings | Microscopic findings: A group of findings within the histopathology examination. The Runtime name constraint allows identification of the type of histopathology examination performed. |
| Histopathology finding | Histopathology finding: Details of an individual histopathology finding, often related to a specific anatomical location or specimen. |
| Description | Description: A narrative description of the histopathology finding.Annotations
|
| Microscopy renal biopsy non neoplastic | Microscopy renal biopsy non neoplastic: Microscopic findings related to a non-neoplastic renal biopsy |
| Renal biopsy overall description | Renal biopsy overall description: Describes tissue types in the renal biopsy specimen. |
| Cortex | Cortex: Cortical tissue present, alternatively core length with cortical tissue, alternatively proportion of cortical tissue in relation to the core with renal tissue.
|
| Medulla | Medulla: Medullary tissue present, alternatively core length with medullary tissue, alternatively proportion of medullary tissue in relation to the core with renal tissue.
|
| Renale capsule | Renale capsule: A statement whether the renal capsule is present. |
| Other tissue elements | Other tissue elements: Description of other tissue elements, e.g. muscle tissue.
|
| Glomeruli | Glomeruli: Description of glomerular changes. |
| Glomeruli | Glomeruli: The maximum number of glomeruli irrespective of size present in one section; structures consisting of Bowman's capsule with empty Bowman's space are excluded. |
| Scorable glomeruli | Scorable glomeruli: The number of glomeruli judged as adequate for scoring by the reporting pathologist. |
| Glomeruli solely with necrosis | Glomeruli solely with necrosis: The number of glomeruli showing fibrinoid necrosis without crescent formation. |
| Glomeruli with crescents | Glomeruli with crescents: The number of glomeruli showing cellular or fibrocellular crescents. |
| Glomeruli with ischemic changes | Glomeruli with ischemic changes: The number of glomeruli showing some degree of tuft retraction and wrinkling of capillary walls. Chronic ischemic changes might show fibrosis of Bowman's capsule. |
| Glomeruli with adhesions | Glomeruli with adhesions: The number of glomeruli showing coneective tissue connections between the tuft and Bowman's capsule without overt sclerosis. |
| Glomeruli with segmental sclerosis | Glomeruli with segmental sclerosis: The number of glomeruli showing obliteration of capillary lumen by extracellular matrix in a portion of the tuft area with or without adhesions to the Bowman capsule, hyaline lesions, foam cells. |
| Glomeruli with global sclerosis | Glomeruli with global sclerosis: The number of glomeruli showing scarring with obliteration of capillary lumen by extracellular matrix in the entire or nearly entire glomerular tuft. |
| Normal glomeruli | Normal glomeruli: The number of glomeruli which appear normal without major changes. |
| Mesangium | Mesangium: Description of mesangial changes. |
| No abnormality detected | No abnormality detected: Statement that no abnormality was detected on examination of the mesangial areas. |
| Details of the mesangium | Details of the mesangium: A narrative description of mesangial changes. |
| Mesangial matrix increase | Mesangial matrix increase: Visual assessment of the amount of mesangial matrix.
|
| Mesangial hypercellularity | Mesangial hypercellularity: A visual assessment of the cellularity of the mesangium. Normally there are 1 - 3 cells per mesangial area. The score is based on the most cellular mesangial area. Mesangial areas adjacent to the vascular stalk should not be scored. Definitions based on Roberts et al, 2009.
|
| Mesangial nodularity | Mesangial nodularity: A visual assessment of the presence of acellular PAS positive mesangial nodules.
|
| Capillaries | Capillaries: Description of glomerular capillary changes. |
| No abnormality detected | No abnormality detected: Statement that no abnormality was detected on examination of the glomerular capillaries. |
| Details of glomerular capillaries | Details of glomerular capillaries: A narrative description of glomerular capillary changes. |
| Capillary wall thickening | Capillary wall thickening: A visual assessment of the capillary wall thickness.
|
| Capillary wall duplication | Capillary wall duplication: A visual assessment of the presence of capillary wall duplication.
|
| Mesangial cell interposition | Mesangial cell interposition: A visual assesment of the presence of interposed cells in the capillary periphery.
|
| Capillary lumen | Capillary lumen: Description of changes in the capillary lumens. |
| Thrombi | Thrombi: Findings related to intracapillary thrombi. |
| Thrombi | Thrombi: Visual assessment of intracapillary thrombi.
|
| Thrombus type | Thrombus type: Type of intracapillary thrombi.
|
| Endocapillary hypercellularity | Endocapillary hypercellularity: Findings related to endocapillary cellularity. |
| Endocapillary hypercellularity | Endocapillary hypercellularity: Visual assessment of endocapillary hypercellularity.
|
| Cell type | Cell type: Composition of intracapillary cells.
|
| Podocytes | Podocytes: Description of podocyte changes. |
| No abnormality detected | No abnormality detected: Statement that no abnormality was detected on examination of podocytes. |
| Details of podocytes | Details of podocytes: A narrative description of podocyte changes. |
| Hypertrophy | Hypertrophy: Enlarged podocytes often with amphophil cytoplasm.
|
| Bi- or multinucleated podocytes | Bi- or multinucleated podocytes: Podocytes with 2 or more nuclei.
|
| Resorption droplets | Resorption droplets: Podocytes with PAS positive resorption droplets.
|
| Pseudocysts | Pseudocysts: Podocytes with pseudocysts.
|
| Description of glomeruli | Description of glomeruli: A narrative description of glomerular findings, e.g. mesangial and endocapillary cellularity, capillary wall changes, podocytes, Bowman's space. For structured description of specific renal diseases use appropriate cluster (IgA nephropathy, lupus nephritis). |
| Tubules | Tubules: Description of tubular changes. |
| No abnormality detected | No abnormality detected: A statement that no abnormality was detected in renal tubules. |
| Tubular epithelial cell changes | Tubular epithelial cell changes: Description of tubular epithelial cell changes. Multiple choices possible.
|
| Casts in tubules | Casts in tubules: Choose the type of casts present in tubuli. Multiple choices possible.
|
| Tubular casts | Tubular casts: Structured report of kind of tubular casts present. |
| Tamm Horsfall protein | Tamm Horsfall protein: Presence of intratubular Tamm Horsfall protein. |
| Hyaline casts | Hyaline casts: Presence of hyalin casts in tubular lumen. |
| Granular casts | Granular casts: Presence of granular casts in tubular lumen. |
| Detached cells | Detached cells: Detached cells, commonly epithelial cells, present in the tubular lumen. |
| Red blood cells | Red blood cells: Collections of red blood cells or red blood cell casts present in tubular lumen. |
| Granulocytes | Granulocytes: Presence of neutrophil granulocytes in tubular lumen. |
| Mixed casts | Mixed casts: Casts consisting of more than one component. |
| Pigmented casts | Pigmented casts: Discolorated casts e.g. due to hemoglobin, myoglobin, drug pigments, bilirubin, melanin. |
| Myeloma casts | Myeloma casts: Characteristic myeloma casts, often surrounded by reactive tubular epithelial cells. or multinucleated cells, present in tubular lumen. |
| Crystals | Crystals: Crystals present in tubular lumen. |
| Tubular atrophy | Tubular atrophy: Semiquantitative or quantitative assessment of tubular atrophy. |
| Tubular atrophy semiquantitative | Tubular atrophy semiquantitative: Semiquantitative visual assessment of tubular atrophy.
|
| Tubules description | Tubules description: Desription of tubular changes, e.g. hyalin droplet change, acute epithelial damage, cytoplasmic vacuolation, sloughing of cells, loss of brush border. |
| Interstitium | Interstitium: Interstitial changes, especially semiquantitative or quantitative assessment of interstitial fibrosis. |
| No abnormality detected | No abnormality detected: A statement that no abnormality was detected in the renal interstitium. |
| Quantification of interstitial fibrosis | Quantification of interstitial fibrosis: Quantification of interstitial fibrosis by image analysis methods. |
| Technique | Technique: Technique used to quantify fibrosis.
|
| Percentage interstitial fibrosis | Percentage interstitial fibrosis: Percentage of the renal cortical tissue involved by fibrosis. Enheter: % |
| Multimedia representation of image analysis | Multimedia representation of image analysis: Images, graphs and tables from automatic image analysis of interstitial fibrosis. |
| Cortical area with fibrosis estimated | Cortical area with fibrosis estimated: Visual quantification of interstitial fibrosis; The fibrosis percentage is the percentage of abnormal cortical tissue with fibrosis. <=0 % |
| Fibrous tissue estimated | Fibrous tissue estimated: Visual quantification of interstitial fibrosis; The fibrosis percentage is the percentage of all cortical tissue (excluding tubules and glomeruli) occupied by fibrous tissue. Enheter: % |
| Interstitium description | Interstitium description: Description of interstitial changes, e.g. edema, inflammatory cells, deposits. |
| Vasculature | Vasculature: Changes affecting arteries, arterioles, venes and peritubular capillaries. |
| No abnormality detected | No abnormality detected: A statement that no abnormality was detected in the renal vasculature. |
| Number of arteries | Number of arteries: Number of arteries in a renal biopsy. |
| Arteriosclerosis | Arteriosclerosis: Amount of arteriosclerosis in the most affected vessel.
|
| Arteriolosclerosis | Arteriolosclerosis: Amount of arteriolosclerosis in the most affected vessel.
|
| Vasculature description | Vasculature description: Description of vascular changes, e.g. vasculitis, venulitis. For description of severity of arteriosclerosis and arteriolosclerosis use coded text. |
| Amyloid | Amyloid: Findings related to amyloid deposition. |
| Amyloid not detected | Amyloid not detected: A statement that no amyloid deposition was detected. |
| Multimedia representation | Multimedia representation: Images from lesions could be attached here. |
| Pathological interpretation | Pathological interpretation: Single word, phrase of brief description representing the interpretation of the histopathology finding. A coded term is preferred. |
| Test representation | Test representation: Rich text or other multimedia representation of this particular result as issued by the diagnostic service. Multiple formats are allowed but they must be semantically equivalent. |
| Description | Description: A narrative description of the group of histopathology findings. |
| Container 2 | Container 2: Findings and interpretation of histopathology (anatomic pathology) tests performed on tissues and body fluids. |
| Macroscopic findings | Macroscopic findings: A group of findings within the histopathology examination. The Runtime name constraint allows identification of the type of histopathology examination performed. |
| Histopathology finding | Histopathology finding: Details of an individual histopathology finding, often related to a specific anatomical location or specimen. |
| Tissue available | Tissue available: True if the tissue is available for examination. |
| Specimen | Specimen: To record details of a laboratory specimen. |
| Specimen type | Specimen type: The type of specimen to be collected e.g venous blood, prostatic biopsy. Optional[{fhir_mapping=Specimen.type}] |
| Datetime collected | Datetime collected: The date and time that collection has been ordered to take place or has taken place. |
| Sampling conditions | Sampling conditions: Any conditions to be met before the sample should be taken. e.g. fasting, 'full bladder', 'sterile field' or any special instructions on the handling or immediate processing of the sample e.g. centrifuge on receipt. Can also be used to document any known deviations from collection or handling instructions e.g patient was not fasted. |
| Fysiske egenskaper til et objekt | Fysiske egenskaper til et objekt: For registrering av de fysiske egenskaper til et objekt som en kroppsdel eller en lesjon. |
| Navn på det fysiske objektet | Navn på det fysiske objektet: Den aktuelle gjenstanden. Kan være en kroppsdel, enhet eller prøve.
|
| Dimensjon | Dimensjon: Dimensjonene til objektet. |
| Lengde | Lengde: Lengden til objektet. |
| Specimen container | Specimen container: Details of a specimen container. This is often integral to workflow and reporting of pathology specimens, particularly anatomical and histological pathology specimens. |
| Container additive | Container additive: Any special fixative or transport medium requirements.Annotations
|
| Description | Description: A narrative description of the group of histopathology findings. |
| Microscopic findings | Microscopic findings: A group of findings within the histopathology examination. The Runtime name constraint allows identification of the type of histopathology examination performed. |
| Semitynnsnitt | Semitynnsnitt: Details of an individual histopathology finding, often related to a specific anatomical location or specimen. |
| Tissue available | Tissue available: True if the tissue is available for examination. |
| Description | Description: A narrative description of the histopathology finding. |
| Microscopy renal biopsy non neoplastic | Microscopy renal biopsy non neoplastic: Microscopic findings related to a non-neoplastic renal biopsy |
| Renal biopsy overall description | Renal biopsy overall description: Describes tissue types in the renal biopsy specimen. |
| Cortex | Cortex: Cortical tissue present, alternatively core length with cortical tissue, alternatively proportion of cortical tissue in relation to the core with renal tissue.
|
| Medulla | Medulla: Medullary tissue present, alternatively core length with medullary tissue, alternatively proportion of medullary tissue in relation to the core with renal tissue.
|
| Renale capsule | Renale capsule: A statement whether the renal capsule is present. |
| Other tissue elements | Other tissue elements: Description of other tissue elements, e.g. muscle tissue.
|
| Glomeruli | Glomeruli: Description of glomerular changes. |
| Glomeruli | Glomeruli: The maximum number of glomeruli irrespective of size present in one section; structures consisting of Bowman's capsule with empty Bowman's space are excluded. |
| Scorable glomeruli | Scorable glomeruli: The number of glomeruli judged as adequate for scoring by the reporting pathologist. |
| Glomeruli solely with necrosis | Glomeruli solely with necrosis: The number of glomeruli showing fibrinoid necrosis without crescent formation. |
| Glomeruli with crescents | Glomeruli with crescents: The number of glomeruli showing cellular or fibrocellular crescents. |
| Glomeruli with ischemic changes | Glomeruli with ischemic changes: The number of glomeruli showing some degree of tuft retraction and wrinkling of capillary walls. Chronic ischemic changes might show fibrosis of Bowman's capsule. |
| Glomeruli with adhesions | Glomeruli with adhesions: The number of glomeruli showing coneective tissue connections between the tuft and Bowman's capsule without overt sclerosis. |
| Glomeruli with segmental sclerosis | Glomeruli with segmental sclerosis: The number of glomeruli showing obliteration of capillary lumen by extracellular matrix in a portion of the tuft area with or without adhesions to the Bowman capsule, hyaline lesions, foam cells. |
| Glomeruli with global sclerosis | Glomeruli with global sclerosis: The number of glomeruli showing scarring with obliteration of capillary lumen by extracellular matrix in the entire or nearly entire glomerular tuft. |
| Normal glomeruli | Normal glomeruli: The number of glomeruli which appear normal without major changes. |
| Mesangium | Mesangium: Description of mesangial changes. |
| No abnormality detected | No abnormality detected: Statement that no abnormality was detected on examination of the mesangial areas. |
| Details of the mesangium | Details of the mesangium: A narrative description of mesangial changes. |
| Mesangial matrix increase | Mesangial matrix increase: Visual assessment of the amount of mesangial matrix.
|
| Mesangial hypercellularity | Mesangial hypercellularity: A visual assessment of the cellularity of the mesangium. Normally there are 1 - 3 cells per mesangial area. The score is based on the most cellular mesangial area. Mesangial areas adjacent to the vascular stalk should not be scored. Definitions based on Roberts et al, 2009.
|
| Mesangial nodularity | Mesangial nodularity: A visual assessment of the presence of acellular PAS positive mesangial nodules.
|
| Capillaries | Capillaries: Description of glomerular capillary changes. |
| No abnormality detected | No abnormality detected: Statement that no abnormality was detected on examination of the glomerular capillaries. |
| Details of glomerular capillaries | Details of glomerular capillaries: A narrative description of glomerular capillary changes. |
| Capillary wall thickening | Capillary wall thickening: A visual assessment of the capillary wall thickness.
|
| Capillary wall duplication | Capillary wall duplication: A visual assessment of the presence of capillary wall duplication.
|
| Mesangial cell interposition | Mesangial cell interposition: A visual assesment of the presence of interposed cells in the capillary periphery.
|
| Capillary lumen | Capillary lumen: Description of changes in the capillary lumens. |
| Thrombi | Thrombi: Findings related to intracapillary thrombi. |
| Thrombi | Thrombi: Visual assessment of intracapillary thrombi.
|
| Thrombus type | Thrombus type: Type of intracapillary thrombi.
|
| Endocapillary hypercellularity | Endocapillary hypercellularity: Findings related to endocapillary cellularity. |
| Endocapillary hypercellularity | Endocapillary hypercellularity: Visual assessment of endocapillary hypercellularity.
|
| Cell type | Cell type: Composition of intracapillary cells.
|
| Podocytes | Podocytes: Description of podocyte changes. |
| No abnormality detected | No abnormality detected: Statement that no abnormality was detected on examination of podocytes. |
| Details of podocytes | Details of podocytes: A narrative description of podocyte changes. |
| Hypertrophy | Hypertrophy: Enlarged podocytes often with amphophil cytoplasm.
|
| Bi- or multinucleated podocytes | Bi- or multinucleated podocytes: Podocytes with 2 or more nuclei.
|
| Resorption droplets | Resorption droplets: Podocytes with PAS positive resorption droplets.
|
| Pseudocysts | Pseudocysts: Podocytes with pseudocysts.
|
| Description of glomeruli | Description of glomeruli: A narrative description of glomerular findings, e.g. mesangial and endocapillary cellularity, capillary wall changes, podocytes, Bowman's space. For structured description of specific renal diseases use appropriate cluster (IgA nephropathy, lupus nephritis). |
| Tubules | Tubules: Description of tubular changes. |
| No abnormality detected | No abnormality detected: A statement that no abnormality was detected in renal tubules. |
| Tubular epithelial cell changes | Tubular epithelial cell changes: Description of tubular epithelial cell changes. Multiple choices possible.
|
| Casts in tubules | Casts in tubules: Choose the type of casts present in tubuli. Multiple choices possible.
|
| Tubular casts | Tubular casts: Structured report of kind of tubular casts present. |
| Tamm Horsfall protein | Tamm Horsfall protein: Presence of intratubular Tamm Horsfall protein. |
| Hyaline casts | Hyaline casts: Presence of hyalin casts in tubular lumen. |
| Granular casts | Granular casts: Presence of granular casts in tubular lumen. |
| Detached cells | Detached cells: Detached cells, commonly epithelial cells, present in the tubular lumen. |
| Red blood cells | Red blood cells: Collections of red blood cells or red blood cell casts present in tubular lumen. |
| Granulocytes | Granulocytes: Presence of neutrophil granulocytes in tubular lumen. |
| Mixed casts | Mixed casts: Casts consisting of more than one component. |
| Pigmented casts | Pigmented casts: Discolorated casts e.g. due to hemoglobin, myoglobin, drug pigments, bilirubin, melanin. |
| Myeloma casts | Myeloma casts: Characteristic myeloma casts, often surrounded by reactive tubular epithelial cells. or multinucleated cells, present in tubular lumen. |
| Crystals | Crystals: Crystals present in tubular lumen. |
| Tubular atrophy | Tubular atrophy: Semiquantitative or quantitative assessment of tubular atrophy. |
| Tubular atrophy semiquantitative | Tubular atrophy semiquantitative: Semiquantitative visual assessment of tubular atrophy.
|
| Tubules description | Tubules description: Desription of tubular changes, e.g. hyalin droplet change, acute epithelial damage, cytoplasmic vacuolation, sloughing of cells, loss of brush border. |
| Interstitium | Interstitium: Interstitial changes, especially semiquantitative or quantitative assessment of interstitial fibrosis. |
| No abnormality detected | No abnormality detected: A statement that no abnormality was detected in the renal interstitium. |
| Quantification of interstitial fibrosis | Quantification of interstitial fibrosis: Quantification of interstitial fibrosis by image analysis methods. |
| Technique | Technique: Technique used to quantify fibrosis.
|
| Percentage interstitial fibrosis | Percentage interstitial fibrosis: Percentage of the renal cortical tissue involved by fibrosis. Enheter: % |
| Multimedia representation of image analysis | Multimedia representation of image analysis: Images, graphs and tables from automatic image analysis of interstitial fibrosis. |
| Cortical area with fibrosis estimated | Cortical area with fibrosis estimated: Visual quantification of interstitial fibrosis; The fibrosis percentage is the percentage of abnormal cortical tissue with fibrosis. <=0 % |
| Fibrous tissue estimated | Fibrous tissue estimated: Visual quantification of interstitial fibrosis; The fibrosis percentage is the percentage of all cortical tissue (excluding tubules and glomeruli) occupied by fibrous tissue. Enheter: % |
| Interstitium description | Interstitium description: Description of interstitial changes, e.g. edema, inflammatory cells, deposits. |
| Vasculature | Vasculature: Changes affecting arteries, arterioles, venes and peritubular capillaries. |
| No abnormality detected | No abnormality detected: A statement that no abnormality was detected in the renal vasculature. |
| Number of arteries | Number of arteries: Number of arteries in a renal biopsy. |
| Arteriosclerosis | Arteriosclerosis: Amount of arteriosclerosis in the most affected vessel.
|
| Arteriolosclerosis | Arteriolosclerosis: Amount of arteriolosclerosis in the most affected vessel.
|
| Vasculature description | Vasculature description: Description of vascular changes, e.g. vasculitis, venulitis. For description of severity of arteriosclerosis and arteriolosclerosis use coded text. |
| Amyloid | Amyloid: Findings related to amyloid deposition. |
| Amyloid not detected | Amyloid not detected: A statement that no amyloid deposition was detected. |
| Multimedia representation | Multimedia representation: Images from lesions could be attached here. |
| Pathological interpretation | Pathological interpretation: Single word, phrase of brief description representing the interpretation of the histopathology finding. A coded term is preferred. |
| Test representation | Test representation: Rich text or other multimedia representation of this particular result as issued by the diagnostic service. Multiple formats are allowed but they must be semantically equivalent. |
| Elektronmikroskopi | Elektronmikroskopi: Details of an individual histopathology finding, often related to a specific anatomical location or specimen. |
| Tissue available | Tissue available: True if the tissue is available for examination. |
| Description | Description: A narrative description of the histopathology finding.Annotations
|
| Pathological interpretation | Pathological interpretation: Single word, phrase of brief description representing the interpretation of the histopathology finding. A coded term is preferred. |
| Test representation | Test representation: Rich text or other multimedia representation of this particular result as issued by the diagnostic service. Multiple formats are allowed but they must be semantically equivalent. |
| Description | Description: A narrative description of the group of histopathology findings. |
| Vurdering | Vurdering: Konsis, tekstlig tolkning av laboratoriesvaret, satt i en klinisk sammenheng. |
| Diagnose fritekst | Diagnose fritekst: Enkeltord, frase eller kort beskrivelse som beskriver teksten i "Konklusjon". Koding med en terminologi foretrekkes, der det er mulig. |
| Diagnose terminologi | Diagnose terminologi: Enkeltord, frase eller kort beskrivelse som beskriver teksten i "Konklusjon". Koding med en terminologi foretrekkes, der det er mulig. |
| Kommentar | Kommentar: Tekstlig tilleggsinformasjon som ikke er registrert i andre felt. |
| Protocol | Protocol: *@ internal @(en) |
| SvarID | SvarID: Lokal ID som er gitt til analysesvaret av laboratoriesystemet (LIS).Annotations
|